tbuckley/cabot-search huggingface dataset:
P2.05-08 Immunotherapy Prognostication with Thoracic CT Contrastive Self-Supervised Learning in Patients with Non-Small Cell Lung Cancer
Authors: T. Chaunzwa, S.L. Pai, Q. Li, B. Ricciuti, A. Gupta, I. Achour, R. Reyes, S. Bernatz, J. Alessi, D. Bontempi, R. Mak, M. Awad, H. Aerts
Journal: Journal of Thoracic Oncology (2023)
P2.12-03 COVALENT-102: A Phase 1/1b Study of BMF-219, A Menin Inhibitor in Patients with Unresectable, Metastatic NSCLC, PDAC, and CRC
Authors: S. Patel, D. Hong, S.A. Cohen, C. Fountzilas, D. Sommerhalder, S. Radhi, A. Benson, K. He, E. Pisick, A. Bessudo, H. Duvivier, T. Tong, B. Munneke, Y. Kosaka, U. Ahmed, A. Cacovean, S. Morris, T. Butler, A. Spira
Journal: Journal of Thoracic Oncology (2023)
EP08.02-35 Prognostic Impacts of Lymphovascular Invasion of Resected Lung Adenocarcinoma after Induction Chemoradiotherapy
Authors: T. Kabuto, T. Menju, S. Nishikawa, K. Terada, A. Yoshizawa, N. Aruga, K. Matsumoto, Y. Imamura, S. Tanaka, Y. Yutaka, Y. Yamada, A. Ohsumi, D. Nakajima, M. Hamaji, H. Date
Journal: Journal of Thoracic Oncology (2023)
P2.09-36 Efficacy and Safety of Furmonertinib 160 mg as First-line Therapy for EGFR-mutated Advanced NSCLC Patients with CNS Metastases
Authors: X. Zheng, J. An, Y. Hua, X. Ding, S. Sun, H. Shi, L. Zhou, W. Xu, F. Wei, K. Wang, X. Li
Journal: Journal of Thoracic Oncology (2023)
EP08.04-01 Predictors and Outcomes of Pneumonitis in Non-Small Cell Lung Cancer Patients treated with Consolidative Durvalumab
Authors: C.A. Lim, S. Ghosh, H. Morrison, D. Meyers, I. Stukalin, S. Dolter, H. Grosjean, M. Kerba, D. Hao, A. Pabani
Journal: Journal of Thoracic Oncology (2023)
P2.14-07 Updated Results of Camrelizumab Plus Nab-Paclitaxel and Carboplatin as First-Line Treatment for ES-SCLC: A Phase II Trial
Authors: S. Ren, J. Yu, A. Xiong, Q. Wang, L. Wang, B. Chen, M. Yang, W. Li, J. Yuan, C. Zhao, C. Zhou
Journal: Journal of Thoracic Oncology (2023)
EP07.01-21 A 22 to 23G Intraoperative Needle Biopsy Does Not Affect Recurrence of Preoperatively Undiagnosed Stage 1 Lung Cancer
Authors: Y. Imamura, S. Nishikawa, N. Aruga, T. Kabuto, K. Matsumoto, S. Tanaka, Y. Yutaka, D. Nakajima, A. Ohsumi, M. Hamaji, T. Menju, H. Date
Journal: Journal of Thoracic Oncology (2023)
P2.07-03 Factors Associated with Disease Progression after Discontinuation of Immunotherapy for Immune-Related Toxicity in Non-small Cell Lung Cancer
Authors: F. Pecci, R. Thummalapalli, S. Alden, B. Ricciuti, J.V. Alessi, A. Elkrief, H. Rizvi, X. Wang, J.V. Egger, V.R. Vaz, A. Barrichello, G. Lamberti, A. Di Federico, M. Gandhi, M. Nishino, B.E. Johnson, M.D. Hellmann, A.J. Schoenfeld, M.M. Awad
Journal: Journal of Thoracic Oncology (2023)
EP04.05-02 Incidentally-Detected Lung Cancer in Persons Too Young or Too Old for Lung Cancer Screening
Authors: W. Liao, N.R. Faris, C. Fehnel, J. Goss, C.J. Shepherd, T. Qureshi, S. Peppers, A. Harris, A. Porter, A.T. Matthews, M.A. Ray, M.P. Smeltzer, R.U. Osarogiagbon
Journal: Journal of Thoracic Oncology (2023)
P2.06-02 DEnosumab plus PD-1 Inhibitor for MAINtenance Therapy of Advanced KRAS-Mutant NSCLC - A Prospective, Single-Arm, Phase II Study (DEMAIN)
Authors: H. Li, H.-Y. Xu, J.-C. Duan, Z.-J. Wang, J. Zhong, Y.-Y. Cui, Q. Fang, S.-Y. Lei, Y. Wang
Journal: Journal of Thoracic Oncology (2023)
P2.09-27 Trials in Progress: Phase 1a/b study of ELVN-002, in Solid Tumors with HER2 Mutations, Amplification or Overexpression
Authors: S. Bowyer, A. Spira, T. Patil, J. Lyssikatos, W. Deng, H. Collins, B.C. Cho
Journal: Journal of Thoracic Oncology (2023)
P1.28-12 Korean Real-world Data on Unresectable Stage III Non-Small Cell Lung Cancer Patients Treated with Durvalumab after Chemoradiotherapy
Authors: H.-J. Oh, C.-K. Park, Y.-C. Kim, Y.-H. Kim, S.-J. Ahn, W.G. Jeong, J.Y. Lee, J.C. Lee, C.M. Choi, W. Ji, S.Y. Song, J. Choi, S.Y. Lee, H. Kim, S.Y. Lee, J. Park, S.H. Yoon, J.H. Joo, I.-J. Oh
Journal: Journal of Thoracic Oncology (2023)
P2.16-03 RYZ101 + Carboplatin + Etoposide + Atezolizumab in Somatostatin Receptor Expressing Extensive-Stage Small-Cell Lung Cancer
Authors: C. Mulvey, R. Langdon, J. Berilgen, A. Chiappori, J.M. Rineer, Z. Hao, S. Puri, E. Parent, T. Boike, N. Rivera-Rodriguez, D. Ferreira, J. Li, K. Ma, J. Rearden, S. Moran, A.S. Mansfield
Journal: Journal of Thoracic Oncology (2023)
EP07.02-03 High-Dose Rate Endobronchial Brachytherapy with Palliative and Definitive Intent at a Tertiary Care Hospital
Authors: B. Facer, N. Pastis, J.M. Brownstein, J.K. Pannu, A. Revelo, A.M. Quick, K.E. Haglund, J.C. Grecula, M. Welliver
Journal: Journal of Thoracic Oncology (2023)
P2.05-05 Genomic Variants Associated with Response to Immune Checkpoint Inhibitors Amongst Asian Patients with Advanced NSCLC
Authors: Y. Huang, F. Aminkeng, J.J. Zhao, Y.Y. Soon, A. Kee, Y. Ang, J.L. Low, S.H. Tay, A. Wong, L.D. Bharwani, B.C. Goh, R.A. Soo
Journal: Journal of Thoracic Oncology (2023)
EP08.03-03 S-1 and CDDP with Concurrent TRT Followed by Durvalumab in Elderly Population with Unresectable, LA-NSCLC in Japan: Post-hoc Analysis of SAMURAI
Authors: S. Tanzawa, H. Tanaka, M. Inaba, J. Nakamura, K. Shibata, T. Kishikawa, M. Nakashima, K. Fujiwara, T. Kohyama, H. Ishida, T. Misumi, K. Shiraishi, N. Matsutani, N. Seki, G. SAMURAI
Journal: Journal of Thoracic Oncology (2023)
P1.06-02 Trametinib Plus ANTI-PD-1 Immunotherapy Impairs Tumor Growth and Increases Survival of Lung Cancer through ID1 Downregulation
Authors: A. Puyalto, M. Rodríguez-Remírez, I. López, M. Olmedo, A. Vilalta-Lacarra, I. Macaya, C. Welch, A. Calvo, S. Vicent, D. Ajona, I. Gil-Bazo
Journal: Journal of Thoracic Oncology (2023)
EP11.03-05 Molecular Characterization and Prognosis of Patients with KRAS Mutant Non-small Cell Lung Cancer
Authors: L. Gutiérrez Sainz, J. Villamayor, O. Higuera, P. Cruz Castellanos, D. Viñal Lozano, I. Esteban Rodríguez, R.M. Regojo, A. Peláez García, V. Heredia Soto, M. Mendiola, R. Rosas Alonso, C. Rodríguez Antolín, I. Ibáñez de Cáceres, J. de Castro Carpeño
Journal: Journal of Thoracic Oncology (2023)
EP01.01-23 Provider Perspectives on a Navigational Pilot Study for Cancer Patients within a Tobacco Treatment Program
Authors: C.L. Zawislak, D. Edmondson, A. Brecher, K. Gregory, A. Zambon, Z. Landau, C. Kenny, M.J. Edelman, H. Borghaei, L. Fleisher
Journal: Journal of Thoracic Oncology (2023)
P1.11-02 DYNAMALK: Dynamic ctDNA Profiling in ALK+ NSCLC. A Study of the Australian Registry and Biobank of Thoracic Cancers AURORA
Authors: M. Itchins, F. Abualhial, J. Rogers, L. Briggs, A. McGrath, A. Bolton, B.J. Solomon, N. Pavlakis, M. Alexander
Journal: Journal of Thoracic Oncology (2023)
EP02.01-06 TP53 Mutation Has Significant Impact on Other Driver Genes in Lung Cancer
Authors: Y. Yang, H. Wang, H. Wang, W. Fan, B. Lian, Y. Jin, W. Luo, J. Mao, Y. Feng, Z. Long, H. Xie, M. Huang, L. Zheng, Z. Pan, M. Huang, Y. Wang, Y. Wen, J. Huang
Journal: Journal of Thoracic Oncology (2023)
EP06.03-11 Characterization of KRAS Mutations in Black Patients with NSCLC at an Urban Academic Medical Center
Authors: D. Dressler, J.R. Fuchs, S.V. Menon, M.P. Hewlett, N. Katam, M. Gurley, Y.K. Chae, Y. Boumber, N. Mohindra, C.V. Vakkalagadda, J.D. Patel
Journal: Journal of Thoracic Oncology (2023)
EP03.03-06 The Involvement of Tumor Endothelial Cells in the Regulation of PD-L1 and Tregs in the Immune Microenvironment of Early-stage Lung Adenocarcinoma
Authors: L. Xie, J. Yin, H. Kong, J. Yu, M. Sun, X. Wang, C. Bai, Y. Song, D. Yang
Journal: Journal of Thoracic Oncology (2023)
EP10.01-09 Added Serum Albumin to Lung-mol GPA Score Improves Prediction of Overall Survival in Non-Small Cell Lung Cancer Patients with Brain Metastasis
Authors: C. Pinthaya, C. Charoentum, T. Suksombooncharoen, B.C. Chewaskulyong, T. Ketpueak
Journal: Journal of Thoracic Oncology (2023)
P2.06-05 Durvalumab ± Tremelimumab + Chemotherapy in 1L Metastatic NSCLC: Characterisation of patients with PFS ≥12 months in POSEIDON
Authors: B.C. Cho, I. Diaz Perez, C. Lowery, L. Szadkowski, S. Peters, E.B. Garon, T. Mok, M.L. Johnson
Journal: Journal of Thoracic Oncology (2023)
EP01.01-09 Radiation Exposure in Intraoperative Navigation for Peripheral Small Pulmonary Nodule
Authors: S. Kohmaru, Y. Saito, R. Takeyama, T. Watanabe, S. Shirai, H. Dejima, Y. Yamauchi, I. Kobayashi, Y. Sakao
Journal: Journal of Thoracic Oncology (2023)
P1.22-04 Plasma-First to Accelerate Time to Treatment and Improve Target Detection in Advanced Lung Cancer: A Prospective Study
Authors: M. Garcia Pardo, K. Czarnecka, J.H. Law, Z.J. Fan, T.K. Waddell, K. Yasufuku, G. Liu, L.L. Donahoe, A. Pierre, L.W. Le, T. Gunasegaran, N. Ghumman, P.A. Bradbury, F. Shepherd, A. Sacher, L. Corke, J. Feng, T. Stockley, P. Pal, P. Rogalla, C. Pipinikas, K.D. Howarth, M. Tsao, N.B. Leighl
Journal: Journal of Thoracic Oncology (2023)
EP08.03-02 Nivolumab Plus Ipilimumab in Relapsed Stage III Non-Small Cell Lung Cancer After Durvalumab Following Chemoradiotherapy
Authors: T. Tokito, A. Mouri, S. Watanabe, Y. Nagai, H. Imai, O. Yamaguchi, Y. Saida, K. Kobayashi, K. Kaira, H. Kagamu
Journal: Journal of Thoracic Oncology (2023)
P2.05-15 Distinct EGFR-driven Co-mutation Patterns Influence Atezolizumab Efficacy in NSCLC: Results from POPLAR and OAK Trials
Authors: Y. Liu, W. Zhang, Q. Chen, H. Wang, W. Yue, H. Xia, C. Wei, N. Liu, L. Liu, X. Wang
Journal: Journal of Thoracic Oncology (2023)
P2.05-13 Canakinumab with Standard of Care for Patients with Advanced NSCLC: T-cell Infiltration Analysis in CANOPY-1
Authors: D.S. Tan, E. Felip, G. de Castro Junior, B.J. Solomon, A. Greystoke, B.C. Cho, M. Cobo, T.M. Kim, S. Ganguly, J. Wu, D. Demanse, A.A. Butler, J.C. Brase, C. Bossen, B.E. Johnson
Journal: Journal of Thoracic Oncology (2023)
EP02.01-10 Dysfunction of FBXL5-mediated Ferrous Iron Homeostasis Suppresses Lung Cancer Growth
Authors: H. Hinokuma, Y. Kanamori, C. Shirakami, M. Sanada, Y. Shinchi, E. Matsubara, K. Fujino, K. Ikeda, T. Moroishi, M. Suzuki
Journal: Journal of Thoracic Oncology (2023)
P2.05-03 Association Between Immune-Related Adverse Events and Survival in a Contemporary Metastatic Non-Small Cell Lung Cancer Cohort
Authors: S. Cook, V. Samuel, D. Meyers, I. Stukalin, I. Litt, R. Sangha, D. Morris, D. Heng, A. Pabani, V. Navani
Journal: Journal of Thoracic Oncology (2023)
P2.09-16 Aumolertinib Combined Intrathecal Chemotherapy for LM from EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
Authors: W. Wang, S.B. Fan, X.P. Huang, M.X. Zhong, J. Guo
Journal: Journal of Thoracic Oncology (2023)
P1.08-03 Hyper-Interferon Sensitive Influenza Virus Induces Immune Activation and Overcomes Resistance to Anti-PD-1 in Murine NSCLC
Authors: R. Salehi-rad, Y. Du, T-h. Zhang, B. Liu, S. Dubinett, R. Sun
Journal: Journal of Thoracic Oncology (2023)
EP07.01-22 Identifying the Optimal Number of Lymph Node Stations for Improving Survival in Resections for Non-small Cell Lung Cancer
Authors: M. Ray, A.T. Matthews, N.R. Faris, C. Fehnel, O. Akinbobola, A. Saulsberry, K. Dortch, S. Muhit, M.P. Smeltzer, O. Ogbeide, R.U. Osarogiagbon
Journal: Journal of Thoracic Oncology (2023)
EP08.02-10 Clinicopathological Analyses for Predicting Survival After Salvage Surgery for Initially Unresectable Lung Cancer
Authors: N. Oka, T. Hishida, K. Kaseda, Y. Oshiro, A. Sakurada, K. Sugino, H. Aoki, Y. Ishiguro, T. Imoto, Y. Okubo, K. Masai, K. Asakura, K. Emoto, H. Asamura
Journal: Journal of Thoracic Oncology (2023)
P2.04-02 AVANZAR: Phase III Study of Datopotamab Deruxtecan (Dato-DXd) + Durvalumab + Carboplatin as 1L Treatment of Advanced/mNSCLC
Authors: C. Aggarwal, P. Cheema, O. Arrieta, L. Bonanno, H. Borghaei, Y. Hu, D.-W. Kim, G. de Castro Junior, A. Hepner, C. Deng, M. González del Riego, T. Kato
Journal: Journal of Thoracic Oncology (2023)
P2.09-29 Efficacy of Osimertinib (OSI) vs 1st-Generation TKI Followed by OSI by Clinical Profile in EGFR-Mutant NSCLC (SMILE STUDY)
Authors: E. Auclin, P. Du Rusquec, V. Albarran, F. Aboubakar, H. Gerber, N. Epaillard, G. Recondo, A. De Giglio, H. Berthou, E. Fabre, J.C. Laguna, J.-B. Blaquier, B. Jimenez-Munarriz, M. Tagliamento, A. Di Federico, G. Sacco, J. Minatta, N. Girard, T. Moran-Bueno, R. Lopez-Castro, B. Besse, L. Mezquita
Journal: Journal of Thoracic Oncology (2023)
MA14.09 Development Of A Clinico-Proteo-Metagenomic Classifier For Risk Stratification Of Incidentally-Detected Pulmonary Nodules
Authors: H. Pass, S. Fraraccio, S. Wandro, A. Singh-Taylor, C. Martino, S. Miller-Montgomery, E. Adams, R. Knight, L. Segal, G.D. Sepich-Poore
Journal: Journal of Thoracic Oncology (2023)
EP12.01-06 Metastatic NSCLC with G719X/S781I EGFR-mutations with acquired BRAF V600E mutation - response to Osimertinib, Dabrafenib and Trametinib
Authors: E.M. Urbanska, J.B. Sørensen, L.C. Melchior, E. Santoni-Rugiu
Journal: Journal of Thoracic Oncology (2023)
P2.07-04 Genomic Subtypes of EGFR-Mutant NSCLC and Real-World Progression-Free Survival (rwPFS) with Immunotherapy (IO)
Authors: N. Belani, E. Walzer, M. Deng, E. Handorf, H. Borghaei, J. Treat, M. Clapper, J.N. Bodor
Journal: Journal of Thoracic Oncology (2023)
P2.13-08 Integrated Clinical and Radiomics Approach to Assess the Treatment Outcome of Combined Chemoimmunotherapy in Extensive-Stage SCLC
Authors: Y. Xia, J. Zhao, Y. Zhang, X. Yang, Y. He, P. Tian, C. Huang, M. Chen, K. Huang, Y. Gao, W. Li
Journal: Journal of Thoracic Oncology (2023)
P2.09-17 OSTARA: A Phase II Study of First-line Osimertinib Combined with Amivantamab in EGFRm Advanced Non-Small Cell Lung Cancer
Authors: D.S.W. Tan, N. Amin, M. Madondo, J. Chapaneri, K.H. Tang, R. Taylor, T. Mok
Journal: Journal of Thoracic Oncology (2023)
P2.31-08 Disparities in Representation of Older Adults, Women, Racial/Ethnic Minorities in Lung Cancer Clinical Trials: Meta-analysis
Authors: R. Siddiqi, M.A. Khan, S. Paracha, S.A.A. Naqvi, M. Islam, Z.B. Riaz, U. Anjum, U. Raza, N. Shivani, S.C. Kamran, K. Parikh, N. Duma, J.L. Warner, I.B. Riaz
Journal: Journal of Thoracic Oncology (2023)
EP02.01-05 Using Silibinin to Target STAT3-Positive Reactive Astrocytes for the Treatment of NSCLC Brain Metastases
Authors: J. Bosch-Barrera, E. Teixidor, A. Sanvisens, M. Puigdemont, J. Trallero, A. Vidal Vila, G. Osca, M. Verdaguer Roberte, N. Priego, E. Sais, A. Hernández Martínez, J. Sabaté Ortega, E. Cuyàs, S. Verdura, J. Puig, V. Pineda, M. Martí-Navas, A. Calvo, J.A. Menendez, R. Marcos-Gragera, M. Valiente
Journal: Journal of Thoracic Oncology (2023)
P1.02-02 Co-inhibition of MEK/RTKs Pathways via Trametinib Plus Anlotinib forKRAS-Mutant NSCLC
Authors: J. Lu, M. Hu, Y. Zhao, Y. Zhang, Y. Lou, S. Tao, L. Zhu, Y. Wu, H. Ji, H. Zhong, B. Han
Journal: Journal of Thoracic Oncology (2023)
EP12.01-47 Lazertinib in Pretreated Epidermal Growth Factor Receptor T790M-Mutated Advanced Non-small Cell Lung Cancer: A Real-World Multicenter Study
Authors: B-C. Ahn, H. Kim, J. Lee, J.B. Lee, M.-H. Hong, H.R. Kim, B.C. Cho, S.M. Lim
Journal: Journal of Thoracic Oncology (2023)
MA05.10 Patient-Initiated a Phase II study (WJOG12819L) to Assess the Efficacy of Osimertinib in Patients with EGFR Mutated T790M-Negative NSCLC
Authors: K. Hasegawa, M. Takeda, M. Shimokawa, A. Nakamura, K. Nosaki, Y. Watanabe, T. Kato, D. Hayakawa, H. Tanaka, T. Takahashi, M. Oki, M. Tachihara, D. Fujimoto, H. Hayashi, K. Yamaguchi, S. Yamamoto, E. Iwama, K. Azuma, N. Yamamoto, K. Nakagawa
Journal: Journal of Thoracic Oncology (2023)
P2.09-23 A Multicentre, Real-World Observational Study of First-Line Osimertinib and Post Progression Patterns in EGFR Positive NSCLC (Reiwa Study)
Authors: K. Watanabe, Y. Hosomi, K. Naoki, T. Kato, Y. Tsukita, H. Matsumoto, K. Yoh, Y. Fujisaka, S. Takahashi, S. Takata, K. Usui, K. Kishi, G. Naka, S. Tamano, K. Uemura, H. Kunitoh
Journal: Journal of Thoracic Oncology (2023)
P2.09-09 A Phase 1, 2 Study to Evaluate the Safety and Anti-tumor Activity of JIN-A02 in Patients with EGFR Mutant Advanced NSCLC
Authors: S.M. Lim, B.C. Cho, M. Nagasaka, T. Reungwetwattana, A. Jo, E. Seah, C. Kim, S.-H.I. Ou
Journal: Journal of Thoracic Oncology (2023)
EP08.02-20 A Prospective Study of Gallium-68 Ventilation and Perfusion PET/CT Before, During, and After Radiotherapy in Patients with NSCLC
Authors: N.D. Wallace, N. Hardcastle, M. Bressel, N. Bucknell, L. McIntosh, J. Callahan, M. MacManus, M. Shaw, N. Plumridge, D. Ball, L. Selbie, M. Hofman, T. Kron, D. Steinfort, S. Siva
Journal: Journal of Thoracic Oncology (2023)
EP12.01-20 Amivantamab: Prolonged Survivor in Post-TKI NSCLC with Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutation (ex20ins)
Authors: A. Aguilar, M. González Cao, C. Mayo de las Casas, M.A. Molina, C. Aguado Esteban, J. Bosch Barrera, R. Rosell
Journal: Journal of Thoracic Oncology (2023)
EP06.02-04 The Relationship between Pathologic and Molecular Characteristics and PD-L1 Expression in Surgically Resected Non-small Cell Lung Cancer
Authors: A. Ito, T. Tarukawa, Y. Suzuki, T. Sakaguchi, K. Ito, K. Fujiwara, Y. Nishii, T. Osamu, H. Yasui, O. Hataji
Journal: Journal of Thoracic Oncology (2023)
P2.06-09 Association of Clinical Response and HRQoL with Long-Term Survival with 1L Nivolumab + Ipilimumab in mNSCLC in CheckMate 227
Authors: M. Reck, G. Worthy, Y. Yuan, J.R. Penrod, R. Lawrance, F. Taylor, S.I. Blum, A. Moisei, A. Lee, T.-E. Ciuleanu, A. Pluzanski, J.-S. Lee, S. Ramalingam, H. Borghaei, K. O’Byrne, L. Paz-Ares, L. Li, R.G. Gupta, J. Bushong, J. Brahmer
Journal: Journal of Thoracic Oncology (2023)
P2.28-02 Impact of the Covid-19 Pandemic on Lung Cancer Diagnosis in a German Comprehensive Cancer Center. Are we still paying the debt?
Authors: J. Winantea, K. Darwiche, W. Eberhardt, M. Schuler, M. Metzenmacher, M. Wiesweg, H. Kalkavan, S. Bölükbas, D. Theegarten, F. Oezkan
Journal: Journal of Thoracic Oncology (2023)
EP07.05-18 Spontaneous Ventilation Video-assisted Thoracoscopic Surgery for Super-elderly NSCLC Patients: a Noninferiority Study.
Authors: Y. Zhao, X. Lu, R. Wang, H. Yu, C. Pan, Y. Wang, W. Chen, H. Liang, L. Lan, J. He
Journal: Journal of Thoracic Oncology (2023)
EP08.03-05 Role of DCE MRI in Predicting Treatment Response to Induction Immunochemotherapy in Locally Advanced NSCLC Patients
Authors: D. Wang, S. Liu, J. Fu, P. Zhang, B. Qiu, H. Liu, J. Guo, Y. Zhou, H. Jiang, S. Yin, K. Peng, C. Xie, H. Liu
Journal: Journal of Thoracic Oncology (2023)
P2.12-09 Targeted and Immunotherapy Associated Cardiotoxicity in Stage IV Lung Cancer Patients with and without Cardiac Comorbidities
Authors: Y. Peng, D. Li, J.A. Wampfler, Y. Luo, A.V. Kumar, Z. Gu, N. Kosuru, N.Y. Yu, Z. Wang, K. Leventakos, V. Ernani, P. Yang
Journal: Journal of Thoracic Oncology (2023)
P1.22-16 ERBB3 and BRAF Mutations as Potential Biomarkers in Non-Small Cell Lung Cancer Patients Under Immunotherapy-Based Treatments
Authors: L. Robado de Lope, R. Serna-Blasco, P. Mediavilla, S. Sanz-Moreno, A. Rodríguez-Festa, P. Gallego-Gil, C. Flores, V. Calvo, A. Collazo-Lorduy, M. Blanco, S. Peña Cabia, P. Diz Tain, M.L. Garrido Onecha, A. Sánchez-Hernández, S. Sequero López, J. Rogado, J. Coves Sarto, A. López Martín, X. Mielgo, S. Vázquez Estévez, V. González-Rumayor, A. Romero, M. Provencio
Journal: Journal of Thoracic Oncology (2023)
P2.09-32 Aumolertinib Plus Anlotinib as 1st-Line Treatment for EGFR Mutant Non-Small Cell Lung Cancer: A Phase II Trial (ALWAYS)
Authors: H.l. Chen, T.t. Xia, G.b. Huang, H.y. Ye, Y.p. Luo, H.g. Chen, M.l. Liu, S.j. Li, Z.x. Yang
Journal: Journal of Thoracic Oncology (2023)
EP02.03-06 Suppression of the Long Non-coding RNA LINC01279 Triggers Autophagy in Lung Cancer by Regulating SIN3A
Authors: None W. Su, J. Wu, X. Huang, X. Li, H. Zhou, Y. Chen, X. Chen, Z. Huang, G. Chen, J. Zhang, Z. Yang
Journal: Journal of Thoracic Oncology (2023)
EP12.01-38 Real-world Outcomes in a U.S. Asian Population with Stage IV NSCLC Treated with Osimertinib Stratified by EGFR Subtype
Authors: Y. Liu, J. Bi, A. Moreira, A. Chachoua, V. Velcheti, S. Lau, S. Punekar, J. Sabari, E. Shum
Journal: Journal of Thoracic Oncology (2023)
P2.20-01 A Precision Medicine Approach by Performing Comprehensive Cancer Genome Profiling of Thymomas and Recurrent Thymomas
Authors: F. Lococo, J. Evangelista, E. De Paolis, M. Chiappetta, A. Dell'Amore, G.M. Comacchio, A. Perrucci, C. Nero, G. Scambia, L. Giacò, F. Pezzuto, F. Calabrese, A. Minucci, E. Bria, F. Rea, S. Margaritora
Journal: Journal of Thoracic Oncology (2023)
P1.22-02 Whole Genome Sequencing Analysis of ALK-rearranged Non-small Cell Lung Cancer
Authors: H. Park, J. Oh, Y. Lee, M.-S. Lee, J.Y. Song, H. Jeong, S. An, J. Choi, Y.-L. Choi, Y.S. Ju
Journal: Journal of Thoracic Oncology (2023)
P1.13-05 Targeting SGLT2 for Early Diagnosis of Lung Adenocarcinoma
Authors: J. Yanagawa, R. Salehi-Rad, P. Saggese, A. Pandey, A. Prosper, D. Aberle, J. Liu, J. Barrio, S.M. Dubinett, C. Scafoglio
Journal: Journal of Thoracic Oncology (2023)
P2.05-14 Understanding Genomic and Social Determinants of Cancer Immunotherapy Outcome across Ancestry
Authors: J. Carrot-Zhang, C. Fong, M. Waters, K. Pichotta, J. Jee, D. Jutagir, D. Ma, T. Perea-Chamblee, S. Kim, K. Arora, B. Mastrogiacomo, T. Tran, S. Maron, M. Berger, G. Riely, N. Schultz, S. Goyert, A. Schoenfeld, F. Gany
Journal: Journal of Thoracic Oncology (2023)
EP07.04-21 Lymphatic Vascular Invasion: Diagnostic Variability and Overall Survival Impact on Patients Undergoing Surgical Resection of NSCLC
Authors: K. Nwanwene, R. Voland, J. Khatri, M. Abdallah, T. Wright, M.T. Tirona, T. Pacioles, J. Dotson, M.O. Jamil, M. DeCamp, D. Zander, J. Flickinger, M.H. Cooper, Y. Shweihat, J.M. Varlotto
Journal: Journal of Thoracic Oncology (2023)
P2.08-05 IMRPrinter: A Phase 1/1b Trial of IMU-201 (PD1-Vaxx) as Monotherapy or in Combination with Atezolizumab +/- Chemotherapy in NSCLC
Authors: M. Boyer, M. Gutierrez, J. Park, G. Richardson, P. Savvides, L. Chong, N. Ede, Y. Kim, U. McCurry, S. Yavrom, G. Selvaggi, D. Carbone
Journal: Journal of Thoracic Oncology (2023)
P1.17-06 Integrated TB and Lung Cancer Screening in Viet Nam
Authors: T.P. Dao, A.J. Codlin, H.Q. Pham, L.N.Q. Vo, R. Forse, A.D. Vo, T.H. Mac, H.T.M. Dang, L.H. Nguyen, H.T. Truong, H.B. Nguyen, L.V. Dinh
Journal: Journal of Thoracic Oncology (2023)
P1.13-02 Deep Multi-omic Blood-Based Biomarker Discovery in People with Smoking History Demonstrates High Early Detection of NSCLC
Authors: E. Khaledian, S. Ramaswamy, M. Liu, L. Yarmus, M. Ramaiah, B. Wilcox, C. Belthangady, B. Koh, P. Ma
Journal: Journal of Thoracic Oncology (2023)
EP12.01-10 Predictors of Poor Outcomes Among Patients Receiving 1st-Line Osimertinib for Advanced EGFR Mutated Non-Small Cell Lung Cancer
Authors: F. Desland, B.G. Fitzgerald, R.S. Sheppard, G. Van Hyfte, M. Shimkus, N.C. Rohs, R. Veluswamy, C.D. Rolfo, T.U. Marron, C.B. Smith, J.E. Gomez, D.B. Doroshow
Journal: Journal of Thoracic Oncology (2023)
P1.08-02 Exploring Autophagy Flux-Related Molecules for Overcoming EGFR TKI Resistance
Authors: J.-H. Kang, J.-O. Kim, J.-Y. Shin, M.-Y. Kim, M.-R. Lee, S. Kim, H. Lee, K. Lee, S.R. Baek, J.I. Kim, D. Jeon, Y.S. Lee
Journal: Journal of Thoracic Oncology (2023)
P1.21-15 Prognostic Value of Change in Platelet Volume for Patients with Metastatic Non-small Cell Lung Cancer Treated with Pembrolizumab
Authors: M. Li, S. Zhao, K. Chian, K. Chakravarthy, H. Kwon, T. Gauntner, N. Jones, A. Secor, P. Das, N. Surya, B. Zehr, D. Spakowicz, L. Wei, K. He, A. Alahmadi, R. Memmott, J. Kaufman, P.G. Shields, Z. Li, D.P. Carbone, C.J. Presley, G.A. Otterson, D.H. Owen
Journal: Journal of Thoracic Oncology (2023)
P1.15-02 Cardiovascular implications of Lung Cancer Screening Program: The Smokers health Multiple Actions (SMAC) Study
Authors: G. Ferrante, A. Rossi, E. Dieci, G. Favaro, B. Pagliaro, E. Voulaz, M. Profili, E. Lanza, D. Pistillo, P. Muriana, G. Condorelli, G. Veronesi
Journal: Journal of Thoracic Oncology (2023)
P2.14-02 First-Line Envafolimab plus Carboplatin-etoposide in Extensive-Stage Small-Cell Lung Cancer: a Single-Arm Phase II Study
Authors: S. Sun, X. Zhao, J. Zhang, X. Zhang, Q. Han, X. Yan, Y. Zhu, J. Wang, S. Jiao
Journal: Journal of Thoracic Oncology (2023)
EP09.01-06 Outcomes of Surgical Treatment for Stage IV Non-Small Cell Lung Cancer (NSCLC) in a Population-Based Cohort
Authors: O. Akinbobola, A. Minhas, O. Ogbeide, N. Faris, C. Fehnel, A. Saulsberry, K. Dortch, A. Matthews, M.P. Smeltzer, M.A. Ray, R.U. Osarogiagbon
Journal: Journal of Thoracic Oncology (2023)